Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority trial of enfuvirtide continuation versus substitution with raltegravir in virologically suppressed HIV-1 patients
2007-000162-20Phase 3Completed
- Sponsor
- ANRS
- Start
- Feb 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of raltegravir and enfuvirtide in Human immunodeficiency virus infection type 1 (2 arms), sponsored by ANRS. Primary endpoint: Virologic failure through week 24. Started Feb 2007; status: completed.
02
Drugs
raltegravirenfuvirtide
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2007-000162-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000162-20.